BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37715213)

  • 1. Implementation of risk stratification within bowel cancer screening: a community jury study exploring public acceptability and communication needs.
    Taylor LC; Dennison RA; Griffin SJ; John SD; Lansdorp-Vogelaar I; Thomas CV; Thomas R; Usher-Smith JA
    BMC Public Health; 2023 Sep; 23(1):1798. PubMed ID: 37715213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.
    Dennison RA; Boscott RA; Thomas R; Griffin SJ; Harrison H; John SD; Moorthie SA; Morris S; Rossi SH; Stewart GD; Thomas CV; Usher-Smith JA
    Health Expect; 2022 Aug; 25(4):1789-1806. PubMed ID: 35526275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of risk stratification within population-based cancer screening from the perspective of the general public: A mixed-methods systematic review.
    Taylor LC; Hutchinson A; Law K; Shah V; Usher-Smith JA; Dennison RA
    Health Expect; 2023 Jun; 26(3):989-1008. PubMed ID: 36852880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A discrete choice experiment to understand public preferences and priorities for risk-stratified bowel cancer screening programmes in the UK.
    Dennison RA; Thomas CV; Morris S; Usher-Smith JA
    Prev Med; 2023 Dec; 177():107786. PubMed ID: 37984646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Preferences for Determining Eligibility for Screening in Risk-Stratified Cancer Screening Programs: A Discrete Choice Experiment.
    Dennison RA; Taylor LC; Morris S; Boscott RA; Harrison H; Moorthie SA; Rossi SH; Stewart GD; Usher-Smith JA
    Med Decis Making; 2023 Apr; 43(3):374-386. PubMed ID: 36786399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of risk stratification within population-based cancer screening from the perspective of healthcare professionals: A mixed methods systematic review and recommendations to support implementation.
    Taylor LC; Law K; Hutchinson A; Dennison RA; Usher-Smith JA
    PLoS One; 2023; 18(2):e0279201. PubMed ID: 36827432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis.
    Thomas C; Mandrik O; Saunders CL; Thompson D; Whyte S; Griffin S; Usher-Smith JA
    Cancer Prev Res (Phila); 2021 Aug; 14(8):811-822. PubMed ID: 34039685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of implementing risk stratification into a national breast cancer screening programme: a focus group study investigating the perspectives of healthcare personnel responsible for delivery.
    French DP; Woof VG; Ruane H; Evans DG; Ulph F; Donnelly LS
    BMC Womens Health; 2022 May; 22(1):142. PubMed ID: 35501791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study.
    Jallow M; Black G; van Os S; Baldwin DR; Brain KE; Donnelly M; Janes SM; Kurtidu C; McCutchan G; Robb KA; Ruparel M; Quaife SL
    Health Expect; 2022 Aug; 25(4):1776-1788. PubMed ID: 35475542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted screening for colorectal cancer in high-risk individuals.
    Wong MC; Wong SH; Ng SC; Wu JC; Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):941-51. PubMed ID: 26651255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
    Hawkins R; McWilliams L; Ulph F; Evans DG; French DP
    BMC Cancer; 2022 Oct; 22(1):1058. PubMed ID: 36224549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening.
    Dyer KE; Shires DA; Flocke SA; Hawley ST; Jones RM; Resnicow K; Shin Y; Lafata JE
    Am J Prev Med; 2019 Feb; 56(2):271-280. PubMed ID: 30554975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.
    Usher-Smith JA; Harvey-Kelly LLW; Rossi SH; Harrison H; Griffin SJ; Stewart GD
    Health Expect; 2021 Apr; 24(2):341-351. PubMed ID: 33264472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public perceptions of communicating information about bowel cancer screening.
    Woodrow C; Watson E; Rozmovits L; Parker R; Austoker J
    Health Expect; 2008 Mar; 11(1):16-25. PubMed ID: 18275399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communication to promote and support physical distancing for COVID-19 prevention and control.
    Ryan RE; Silke C; Parkhill A; Virgona A; Merner B; Hurley S; Walsh L; de Moel-Mandel C; Schonfeld L; Edwards AG; Kaufman J; Cooper A; Chung RKY; Solo K; Hellard M; Di Tanna GL; Pedrana A; Saich F; Hill S
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015144. PubMed ID: 37811673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.
    Rainey L; van der Waal D; Jervaeus A; Donnelly LS; Evans DG; Hammarström M; Hall P; Wengström Y; Broeders MJM
    BMC Cancer; 2020 Mar; 20(1):247. PubMed ID: 32209062
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.